Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim

Hideharu Hagiya; Maya Kimura; Toru Miyamoto; Yuto Haruki; Fumio Otsuka

doi:10.2169/internalmedicine.53.0679

Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim

Hideharu Hagiya, Maya Kimura, Toru Miyamoto, Yuto Haruki, Fumio Otsuka

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a self-limiting type of drug eruption that frequently occurs as a reaction to antibiotics, particularly penicillins or macrolides. Daptomycin (DAP) is a newly developed antibiotic that specifically targets methicillin-resistant Staphylococcus aureus infection. We herein present the case of a 77-year-old severe burn victim who was diagnosed with DAP-induced AGEP while receiving treatment in an intensive care unit. Although rare, physicians should be aware that the administration of DAP can cause AGEP, which may complicate the clinical course of patients with a high fever and inflammation.

Original language	English
Pages (from-to)	511-514
Number of pages	4
Journal	Internal Medicine
Volume	53
Issue number	5
DOIs	https://doi.org/10.2169/internalmedicine.53.0679
Publication status	Published - 2014

Keywords

Acute generalized exanthematous pustulosis
Burn
Daptomycin
Intensive care unit
Methicillinresistant Staphylococcus aureus

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.2169/internalmedicine.53.0679

Fingerprint Dive into the research topics of 'Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim'. Together they form a unique fingerprint.

Cite this

@article{4f8a9767044d48e0884a1673d1b165df,

title = "Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim",

abstract = "Acute generalized exanthematous pustulosis (AGEP) is a self-limiting type of drug eruption that frequently occurs as a reaction to antibiotics, particularly penicillins or macrolides. Daptomycin (DAP) is a newly developed antibiotic that specifically targets methicillin-resistant Staphylococcus aureus infection. We herein present the case of a 77-year-old severe burn victim who was diagnosed with DAP-induced AGEP while receiving treatment in an intensive care unit. Although rare, physicians should be aware that the administration of DAP can cause AGEP, which may complicate the clinical course of patients with a high fever and inflammation.",

keywords = "Acute generalized exanthematous pustulosis, Burn, Daptomycin, Intensive care unit, Methicillinresistant Staphylococcus aureus",

author = "Hideharu Hagiya and Maya Kimura and Toru Miyamoto and Yuto Haruki and Fumio Otsuka",

year = "2014",

doi = "10.2169/internalmedicine.53.0679",

language = "English",

volume = "53",

pages = "511--514",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "5",

}

TY - JOUR

T1 - Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim

AU - Hagiya, Hideharu

AU - Kimura, Maya

AU - Miyamoto, Toru

AU - Haruki, Yuto

AU - Otsuka, Fumio

PY - 2014

Y1 - 2014

N2 - Acute generalized exanthematous pustulosis (AGEP) is a self-limiting type of drug eruption that frequently occurs as a reaction to antibiotics, particularly penicillins or macrolides. Daptomycin (DAP) is a newly developed antibiotic that specifically targets methicillin-resistant Staphylococcus aureus infection. We herein present the case of a 77-year-old severe burn victim who was diagnosed with DAP-induced AGEP while receiving treatment in an intensive care unit. Although rare, physicians should be aware that the administration of DAP can cause AGEP, which may complicate the clinical course of patients with a high fever and inflammation.

AB - Acute generalized exanthematous pustulosis (AGEP) is a self-limiting type of drug eruption that frequently occurs as a reaction to antibiotics, particularly penicillins or macrolides. Daptomycin (DAP) is a newly developed antibiotic that specifically targets methicillin-resistant Staphylococcus aureus infection. We herein present the case of a 77-year-old severe burn victim who was diagnosed with DAP-induced AGEP while receiving treatment in an intensive care unit. Although rare, physicians should be aware that the administration of DAP can cause AGEP, which may complicate the clinical course of patients with a high fever and inflammation.

KW - Acute generalized exanthematous pustulosis

KW - Burn

KW - Daptomycin

KW - Intensive care unit

KW - Methicillinresistant Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=84895099418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895099418&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.53.0679

DO - 10.2169/internalmedicine.53.0679

M3 - Article

C2 - 24583445

AN - SCOPUS:84895099418

VL - 53

SP - 511

EP - 514

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 5

ER -

Acute generalized exanthematous pustulosis caused by Daptomycin in a critically III burn victim

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this